HCPCS Level IIdrugActive
J1411
Inj, hemgenix, per tx dose
BETOS: O1E
Effective: 2023-04-01
Referenced in 1 policies
Description
Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hemgenix
Manufacturer
CSL Behring L.L.C.
HCPCS Dosage
Per Therapeutic Dose
Billing Units
1.0000
39
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.